Literature DB >> 15339215

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

Vijay Kumar1, Owen Lockerbie, Shawn D Keil, Patrick H Ruane, Matthew S Platz, Christopher B Martin, Jean-Luc Ravanat, Jean Cadet, Raymond P Goodrich.   

Abstract

We are developing a technology based on the combined application of riboflavin (RB) and light for inactivating pathogens in blood products while retaining the biological functions of the treated cells and proteins. Virus and bacteria reduction measured by tissue culture infectivity or colony formation with UV light alone and in combination with RB yield equivalent results. The effects of RB as a sensitizing agent on DNA in white cells, bacteria and viruses in combination with UV light exposure have been evaluated. UV-mediated DNA degradation in Jurkat T cells and leukocytes in plasma as measured by the FlowTACS assay was significantly increased in the presence of RB. Agarose gel electrophoretic analysis of DNA in Escherichia coli and leukocytes in plasma demonstrated enhanced DNA degradation in the presence of RB. UV light in combination with RB prevented the reactivation of lambda phage compared with samples irradiated in the absence of RB. UV-mediated oxidative damage in calf thymus DNA was also enhanced in the presence of RB. These observations clearly demonstrate that the presence of RB and UV light selectively enhances damage to the guanine bases in DNA. These data also suggest that the type and extent of damage to DNA for virus in the presence of RB and light make it less likely to be repaired by normal repair pathways available in host cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339215     DOI: 10.1562/2003-12-23-RA-036.1

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  42 in total

1.  Evaluation of combined riboflavin and ultraviolet A as an alternative treatment for keratitis.

Authors:  Zhen-Yong Zhang; Xing-Ru Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-14       Impact factor: 3.117

2.  Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis.

Authors:  Karin Janetzko; Katharina Hinz; Susanne Marschner; Ray Goodrich; Harald Klüter
Journal:  Transfus Med Hemother       Date:  2009-08-07       Impact factor: 3.747

3.  Evaluation of the in vitro antimicrobial properties of ultraviolet A/riboflavin mediated crosslinking on Candida albicans and Fusarium solani.

Authors:  Bing Sun; Zhi-Wei Li; Hai-Qun Yu; Xiang-Chen Tao; Yong Zhang; Guo-Ying Mu
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

Review 4.  Pathogen-reduced platelets for the prevention of bleeding.

Authors:  Lise J Estcourt; Reem Malouf; Sally Hopewell; Marialena Trivella; Carolyn Doree; Simon J Stanworth; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2017-07-30

Review 5.  Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.

Authors:  Americo Cicchetti; Alexandra Berrino; Marina Casini; Paola Codella; Giuseppina Facco; Alessandra Fiore; Giuseppe Marano; Marco Marchetti; Emanuela Midolo; Roberta Minacori; Pietro Refolo; Federica Romano; Matteo Ruggeri; Dario Sacchini; Antonio G Spagnolo; Irene Urbina; Stefania Vaglio; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2016-07       Impact factor: 3.443

6.  Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting.

Authors:  Dragoslav Domanović; Ines Ushiro-Lumb; Veerle Compernolle; Sergio Brusin; Markus Funk; Pierre Gallian; Jørgen Georgsen; Mart Janssen; Teresa Jimenez-Marco; Folke Knutson; Giancarlo M Liumbruno; Polonca Mali; Giuseppe Marano; Yuyun Maryuningsih; Christoph Niederhauser; Constantina Politis; Simonetta Pupella; Guy Rautmann; Karmin Saadat; Imad Sandid; Ana P Sousa; Stefania Vaglio; Claudio Velati; Nicole Verdun; Miguel Vesga; Paolo Rebulla
Journal:  Blood Transfus       Date:  2019-12-11       Impact factor: 3.443

Review 7.  Phototriggered Drug Delivery Using Inorganic Nanomaterials.

Authors:  Qian Liu; Changyou Zhan; Daniel S Kohane
Journal:  Bioconjug Chem       Date:  2016-10-07       Impact factor: 4.774

8.  Controlled inactivation of recombinant viruses with vitamin B2.

Authors:  Shellie M Callahan; Piyanuch Wonganan; Linda J Obenauer-Kutner; Suganto Sutjipto; Joseph D Dekker; Maria A Croyle
Journal:  J Virol Methods       Date:  2007-12-21       Impact factor: 2.014

9.  Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA).

Authors:  Karim Makdoumi; Anders Bäckman; Jes Mortensen; Sven Crafoord
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-18       Impact factor: 3.117

10.  Photoresponsive nanoparticles for drug delivery.

Authors:  Alina Y Rwei; Weiping Wang; Daniel S Kohane
Journal:  Nano Today       Date:  2015-07-15       Impact factor: 20.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.